These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37231722)

  • 1. Nanomedicines: Impactful Approaches for Targeting Pulmonary Diseases.
    Dhoundiyal S; Alam MA; Kaur A; Sharma S
    Pharm Nanotechnol; 2023 May; ():. PubMed ID: 37231722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanostructures for drug delivery in respiratory diseases therapeutics: Revision of current trends and its comparative analysis.
    Ibarra-Sánchez LÁ; Gámez-Méndez A; Martínez-Ruiz M; Nájera-Martínez EF; Morales-Flores BA; Melchor-Martínez EM; Sosa-Hernández JE; Parra-Saldívar R; Iqbal HMN
    J Drug Deliv Sci Technol; 2022 Apr; 70():103219. PubMed ID: 35280919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanotechnology-Assisted Metered-Dose Inhalers (MDIs) for High-Performance Pulmonary Drug Delivery Applications.
    Kumar R; Mehta P; Shankar KR; Rajora MAK; Mishra YK; Mostafavi E; Kaushik A
    Pharm Res; 2022 Nov; 39(11):2831-2855. PubMed ID: 35552983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
    Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
    Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in nanoparticle applications in respiratory disorders: a review.
    Taghavizadeh Yazdi ME; Qayoomian M; Beigoli S; Boskabady MH
    Front Pharmacol; 2023; 14():1059343. PubMed ID: 37538179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhalable nanotherapeutics to improve treatment efficacy for common lung diseases.
    Anderson CF; Grimmett ME; Domalewski CJ; Cui H
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Jan; 12(1):e1586. PubMed ID: 31602823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanosize drug delivery system.
    Mukherjee B
    Curr Pharm Biotechnol; 2013; 14(15):1221. PubMed ID: 25106648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives.
    Ali ES; Sharker SM; Islam MT; Khan IN; Shaw S; Rahman MA; Uddin SJ; Shill MC; Rehman S; Das N; Ahmad S; Shilpi JA; Tripathi S; Mishra SK; Mubarak MS
    Semin Cancer Biol; 2021 Feb; 69():52-68. PubMed ID: 32014609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conventional and Nanotechnology Based Approaches to Combat Chronic Obstructive Pulmonary Disease: Implications for Chronic Airway Diseases.
    Passi M; Shahid S; Chockalingam S; Sundar IK; Packirisamy G
    Int J Nanomedicine; 2020; 15():3803-3826. PubMed ID: 32547029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Trends and Applications of Nanostructure-based Drug Delivery in Alleviating Chronic Obstructive Pulmonary Disease (COPD).
    Nagar L; Gulati N; Saini A; Singh S; Gupta G; MacLoughlin R; Chellappan DK; Dua K; Dureja H
    Curr Drug Deliv; 2024 Mar; ():. PubMed ID: 38445696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opportunities and Challenges for Inhalable Nanomedicine Formulations in Respiratory Diseases: A Review.
    Feng X; Shi Y; Zhang Y; Lei F; Ren R; Tang X
    Int J Nanomedicine; 2024; 19():1509-1538. PubMed ID: 38384321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring state-of-the-art advances in targeted nanomedicines for managing acute and chronic inflammatory lung diseases.
    Maurya S; Srivastava R; Arfin S; Hawthorne S; Jha NK; Agrawal K; Raj S; Rathi B; Kumar A; Raj R; Agrawal S; Paiva-Santos AC; Malik AA; Dua K; Rana R; Ojha S; Jha SK; Sharma A; Kumar D; El-Zahaby SA; Nagar A
    Nanomedicine (Lond); 2022 Dec; 17(30):2245-2264. PubMed ID: 36975758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhalative pharmacotherapy in the future--nanocarriers for pulmonary drug delivery].
    Gessler T
    Pneumologie; 2009 Dec; 63 Suppl 2():S113-6. PubMed ID: 20013540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanotherapeutics: An insight into healthcare and multi-dimensional applications in medical sector of the modern world.
    Prasad M; Lambe UP; Brar B; Shah I; J M; Ranjan K; Rao R; Kumar S; Mahant S; Khurana SK; Iqbal HMN; Dhama K; Misri J; Prasad G
    Biomed Pharmacother; 2018 Jan; 97():1521-1537. PubMed ID: 29793315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanomedicines: A Focus on Nanomaterials as Drug Delivery System with Current Trends and Future Advancement.
    Pandey J; Dubey R; Kate A; Prasad B; Sinha A; Mishra MS
    Drug Res (Stuttg); 2022 Sep; 72(7):355-366. PubMed ID: 35636435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent applications and strategies in nanotechnology for lung diseases.
    Zhong W; Zhang X; Zeng Y; Lin D; Wu J
    Nano Res; 2021; 14(7):2067-2089. PubMed ID: 33456721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the role of nanomedicines for the therapeutic approach of central nervous system dysfunction: At a glance.
    Rhaman MM; Islam MR; Akash S; Mim M; Noor Alam M; Nepovimova E; Valis M; Kuca K; Sharma R
    Front Cell Dev Biol; 2022; 10():989471. PubMed ID: 36120565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selected nanotechnologies and nanostructures for drug delivery, nanomedicine and cure.
    Khan AU; Khan M; Cho MH; Khan MM
    Bioprocess Biosyst Eng; 2020 Aug; 43(8):1339-1357. PubMed ID: 32193755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Next-Generation Polymeric Nanomedicines for Oncology: Perspectives and Future Directions.
    Fletcher NL; Kempe K; Thurecht KJ
    Macromol Rapid Commun; 2020 Sep; 41(18):e2000319. PubMed ID: 32767396
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.